Genetic testing has had a shift in the past ten years, as it has left medical laboratories and entered living rooms.

These genes are strongly associated with cancer risk and may have clear clinical actionability, supporting the goal that each addition to the panel provides meaningful insights for patient care. The ...

Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, announced it will share 11 new research ...

Cellular Research Institute (CRI) Genetics is a company that provides ancestry, genetic, and DNA testing. It offers different test packages that may indicate a person’s history, health, or traits.

Myriad Genetics has broadened the scope of its MyRisk Hereditary Cancer Test for germline testing, adding genes.